Clinical Trial

Evaluation of Safety and Effectiveness of Stryker Surpass Evolve™ Flow Diverter System

Study acronym: EVOLVE
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The primary objective of this study is to evaluate the safety and effectiveness of the Surpass™ Evolve Flow Diverter System in the treatment of unruptured, wide-neck intracranial aneurysms measuring ≤ 12 mm and located on the ICA or its branches
Protocol Amendment History 22 amendments
This ClinicalTrials.gov record has been amended 22 times since 2019-12-09; most recent amendment 2026-04-07.
Status change: Recruiting → Active, Not Recruiting 2023-11-02
Status change: Not Yet Recruiting → Recruiting 2020-03-30
Trial Details
NCT Number NCT04195568
Lead Sponsor Stryker Neurovascular
Conditions Aneurysm, Intracranial
Enrollment 248 participants
Start Date 2020-07-07
Primary Completion 2025-07-14 (estimated)
Study Completion 2028-09-13 (estimated)
Updated on ClinicalTrials.gov 2026-04-09